NATCO Pharma’s stock faced a sharp sell-off, extending its losing streak to the fifth consecutive session after the pharmaceutical company reported a 37.75 per cent year-on-year (YoY ...

Net Sales at Rs 474.80 crore in December 2024 down 37.41% from Rs. 758.60 crore in December 2023. Quarterly Net Profit at Rs. 133.00 crore in December 2024 down 37.47% from Rs. 212.70 crore in ...

Natco Pharma has announced that G. Vasan has been designated as Vice President - (Operations) of the Company w.e.f. 27th February, 2025.G. Vasan is a Postgraduate in Chemistry and having 35+ ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

Natco Pharma share price stands at ₹795.65 as of 11.45 am on March 3, 2025. This reflects a gain of 3.22% from the previous ...

Telangana: Natco Pharma has appointed Bhimrao Dattu Jadhav as Senior Vice President - Operations (Formulations) for Pharma ...

Generic drugmaker Natco Pharma’s consolidated net profit for the December quarter declined 37.75% to ₹132.4 crore compared to ₹212.7 crore a year earlier as revenue from formulations export ...

Natco Pharma Ltd is quoting at Rs 823.5, up 0.06% on the day as on 12:44 IST on the NSE. The stock is down 18.68% in last one year as compared to a 1.09% spurt in NIFTY and a 6.38% spurt in the Nifty ...

Natco Pharma Ltd share price was down by -2.89% from the previous closing price of ₹811.50. Who are peers of Natco Pharma Ltd? The peers of Natco Pharma Ltd are Sun Pharmaceuticals Industries ...

The pharmaceutical firm’s consolidated revenue from operations fell to ₹474.8 crore in Q3 FY2025, down from ₹758.6 crore in the year-ago period, reflecting a 37.4 percent decrease in ...